Abstract
Chronic myelogenous leukemia (CML) is a biphasic neoplasm of the bone marrow that is precipitated by the Philadelphia chromosome, a t(9;22) balanced translocation that encodes a constitutively activated nonreceptor tyrosine kinase termed P210BCR-ABL. This oncoprotein has several intracellular functions; however, the most important effect of P210BCR-ABL leading to cell transformation is phosphorylation of signaling molecules through a constitutively active tyrosine kinase domain. Despite extensive knowledge of the structure and functional domains of BCR-ABL, its precise function in transformation is not known. Progress has been hampered, in part, by the lack of relevant CML models, as cell culture and in vitro assays do not mimic the pathogenesis of CML. Recently, there has been significant progress toward improving murine models that closely resemble human CML. This has allowed researchers to evaluate critical functions of BCR-ABL and has provided a model to test the efficacy of therapeutic medications that block these pathways. Our laboratory has developed two intersecting research programs to better understand the functioning of P210BCR-ABL in leukemogenesis. In one approach, we have developed a murine CML model by transferring HSCs that express BCR-ABL from a retroviral vector. All recipients develop a rapidly fatal MPD that shares several important features with CML. This model has been extremely useful for studying the function of BCR-ABL in the pathogenesis of CML. A second approach utilizes a quantitative cell detachment apparatus capable of measuring small changes in cell adhesion to investigate the mechanism by which P210BCR-ABL causes abnormal cell binding. Altered cell adhesion may contribute to the imbalance between proliferation and self-renewal in the hematopoietic progenitor compartment. To better understand the role abnormal adhesion may play in the development of leukemia, we have attempted to correlate the effects of functional P210BCR-ABL mutants in regulating adhesion and oncogenicity.
Similar content being viewed by others
References
Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Hoglund M . 1997 Genes Chrom. Cancer 20: 299–304
Bashaw GJ, Kidd T, Murray D, Pawson T, Goodman CS . 2000 Cell 101: 703–715
Bazzoni G, Carlesso N, Griffin JD, Hemler ME . 1996 J. Clin. Invest. 98: 521–528
Bernasconi P, Calatroni S, Boni M, Cavigliano PM, Pagnucco G, Bernasconi C . 2001 Haematologica 86: 320–321
Bhatia R, Munthe HA, Verfaillie CM . 1999 Exp. Hematol. 27: 1384–1396
Boettiger D, Huber F, Lynch L, Blystone S . 2001 Mol. Biol. Cell. 12: 1227–1237
Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B . 1997 Cell 88: 197–204
Castellanos A, Pintado B, Weruaga E, Arevalo R, Lopez A, Orfao A, Sanchez-Garcia I . 1996 Int. J. Dev. Biol. 1: suppl 1 283S
Cobaleda C, Gutierrez-Cianca N, Perez-Losada J, Flores T, Garcia-Sanz R, Gonzalez M, Sanchez-Garcia I . 2000 Blood 95: 1007–1013
Cortez D, Kadlec L, Pendergast AM . 1995 Mol. Cell. Biol. 15: 5531–5541
Cozens-Roberts C, Lauffenburger DA, Quinn JA . 1990a Biophys. J. 58: 841–856
Cozens-Roberts C, Quinn JA, Lauffenburger DA . 1990b Biophys. J. 58: 857–872
Cuenco GM, Ren R . 2001 Oncogene 20: 8236–8248
Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830
Daley GQ, Van Etten RA, Baltimore D . 1991 Proc. Natl. Acad. Sci. USA 88: 11335–11338
Dash AB, Williams IR, Kutok JL, Tomasson MH, Anastasiadou E, Lindahl K, Li S, Van Etten RA, Borrow J, Housman D, Druker B, Gilliland DG . 2002 Proc. Natl. Acad. Sci. USA 99: 7622–7627
Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL . 2001 N. Engl. J. Med. 344: 1031–1037
Garcia AJ, Boettiger D . 1999 Biomaterials 20: 2427–2433
Garcia AJ, Huber F, Boettiger D . 1998 J. Biol. Chem. 273: 10988–10993
Gishizky ML, Johnson-White J, Witte ON . 1993 Proc. Natl. Acad. Sci. USA 90: 3755–3759
Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON . 1995 Cell 82: 981–988
Golub TR, Barker GF, Stegmaier K, Gilliland DG . 1997 Curr. Top. Microbiol. Immunol. 220: 67–79
Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG . 1996 Mol. Cell. Biol. 16: 4107–4116
Gordon MY, Goldman JM . 1996 Br. J. Haematol. 95: 10–20
Haskovec C, Ponzetto C, Polak J, Maritano D, Zemanova Z, Serra A, Michalova K, Klamova H, Cermak J, Saglio G . 1998 Br. J. Haematol. 103: 1104–1108
Hawley RG, Fong AZ, Ngan BY, de Lanux VM, Clark SC, Hawley TS . 1993 J. Exp. Med. 178: 1175–1188
Hawley RG, Lieu FH, Fong AZ, Hawley TS . 1994 Gene Ther 1: 136–138
He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS . 2002 Blood 99: 2957–2968
Heaney C, Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S, Druker BJ . 1997 Blood 89: 297–306
Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J . 1990 Nature 344: 251–253
Heisterkamp N, Voncken JW, Senadheera D, Gonzalez-Gomez I, Reichert A, Haataja L, Reinikainen A, Pattengale PK, Groffen J . 2000 Blood 96: 2226–2232
Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H . 1995 Blood 85: 2853–2861
Honda H, Oda H, Suzuki T, Takahashi T, Witte ON, Ozawa K, Ishikawa T, Yazaki Y, Hirai H . 1998 Blood 91: 2067–2075
Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa S, Ishikawa T, Yazaki Y, Hirai H . 2000 Blood 95: 1144–1150
Hurley RW, McCarthy JB, Verfaillie CM . 1995 J. Clin. Invest. 96: 511–519
Jackson P, Baltimore D . 1989 EMBO J. 8: 449–456
Kelliher MA, McLaughlin J, Witte ON, Rosenberg N . 1990 Proc. Natl. Acad. Sci. USA 87: 6649–6653
Kipreos ET, Wang JY . 1992 Science 256: 382–385
Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, Miczek KA, Baltimore D . 1998 Neuron 21: 1259–1272
Konopka JB, Witte ON . 1985 Mol. Cell. Biol. 5: 3116–3123
Kramer A, Horner S, Willer A, Fruehauf S, Hochhaus A, Hallek M, Hehlmann R . 1999 Proc. Natl. Acad. Sci. USA 96: 2087–2092
Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, Aaronson SA . 1986 Science 234: 1545–1548
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE . 1994 Nature 367: 645–648
Lewis ID, McDiarmid LA, Samels LM, To LB, Hughes TP . 1998 Blood 91: 630–640
Li S, Ilaria Jr RL, Million RP, Daley GQ, Van Etten RA . 1999 J. Exp. Med. 189: 1399–1412
Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J . 1992 Cell 70: 431–442
McWhirter JR, Galasso DL, Wang JY . 1993 Mol. Cell. Biol. 13: 7587–7595
McWhirter JR, Wang JY . 1991 Mol. Cell. Biol. 13: 1553–1565
McWhirter JR, Wang JY . 1993 EMBO J. 12: 1533–1546
Melo JV . 1996a Blood 88: 2375–2384
Melo JV . 1996b Leukemia 10: 751–756
Million RP, Aster J, Gilliland DG, Van Etten RA . 2002 Blood 99: 4568–4577
Million RP, Van Etten RA . 2000 Blood 96: 664–670
Mittre H, Leymarie P, Macro M, Leporrier M . 1997 Blood 89: 4239–4241
Nowell PC, Hungerford DA . 1960 Science 132: 1497–1499
Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ . 1994 J. Biol. Chem. 269: 22925–22928
Okuda K, Golub TR, Gilliland DG, Griffin JD . 1996 Oncogene 13: 1147–1152
Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R, Meloni G, Saglio G, Salvatore F, Rotoli B . 1996 Blood 88: 2410–2414
Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM . 1995 Cancer Res. 55: 34–38
Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D . 1998 Blood 92: 3780–3792
Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396
Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON . 1991 Cell 66: 161–171
Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky M . 1993 Cell 75: 175–185
Perego R, Ron D, Kruh GD . 1991 Oncogene 6: 1899–1902
Ren R, Ye ZS, Baltimore D . 1994 Genes Dev. 8: 783–795
Rowley JD . 1973 Nature 243: 290–293
Salgia R, Brunkhorst B, Pisick E, Li JL, Lo SH, Chen LB, Griffin JD . 1995 Oncogene 11: 1149–1155
Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA, Gu H, Griffin JD, Neel BG . 2002 Cancer Cell 1: 479–492
Schott B, Iraj ES, Roninson IB . 1996 Somat. Cell Mol. Genet. 22: 291–309
Skourides PA, Perera SA, Ren R . 1999 Oncogene 18: 1165–1176
Spangrude GJ, Brooks DM, Tumas DB . 1995 Blood 85: 1006–1016
Sparrow EM, Gregg JL . 1960 J. Heat Transfer 294–302
Tachibana N, Raimondi SC, Lauer SJ, Sartain P, Dow LW . 1987 Blood 70: 1458–1461
Tauchi T, Boswell HS, Leibowitz D, Broxmeyer HE . 1994 J. Exp. Med. 179: 167–175
Tauchi T, Miyazawa K, Feng GS, Broxmeyer HE, Toyama K . 1997 J. Biol. Chem. 272: 1389–1394
Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC . 1991 Cell 65: 1153–1163
Van Etten RA . 1999 Trends Cell Biol 9: 179–186
Van Etten RA, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT, Janmey PA . 1994 J. Cell Biol. 124: 325–340
Van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B, Van Roy N, Marynen P, De Paepe A, Slater R, Speleman F . 2001 Genes Chrom. Cancer 30: 274–282
Verfaillie C, Hurley R, Bhatia R, McCarthy JB . 1994 Crit. Rev. Oncol. Hematol. 16: 201–224
Verfaillie CM . 1992 Blood 79: 2821–2826
Verfaillie CM, Hurley R, Lundell BI, Zhao C, Bhatia R . 1997a Acta Haematol. 97: 40–52
Verfaillie CM, Hurley R, Zhao RC, Prosper F, Delforge M, Bhatia R . 1997b J. Lab. Clin. Med. 129: 584–591
Verfaillie CM, McCarthy JB, McGlave PB . 1992 J. Clin. Invest. 90: 1232–1241
Verstovsek S, Lin H, Kantarjian H, Saglio G, De Micheli D, Pane F, Garcia-Manero G, Intrieri M, Rotoli B, Salvatore F, Guo JQ, Talpaz M, Specchia G, Pizzolo G, Liberati AM, Cortes J, Quackenbush RC, Arlinghaus RB . 2002 Cancer 94: 2416–2425
Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N . 1995a Blood 86: 4603–4611
Voncken JW, van Schaick H, Kaartinen V, Deemer K, Coates T, Landing B, Pattengale P, Dorseuil O, Bokoch GM, Groffen J . 1995b Cell 80: 719–728
Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai M, Kaneko H, Sakamoto S, Delia D, Kanamaru A . 1995 Cancer Res. 55: 3192–3196
Wertheim JA, Forsythe K, Druker BJ, Hammer D, Boettiger D, Pear WS . 2002 Blood 99: 4122–4130
Wolff NC, Ilaria Jr RL . 2001 Blood 98: 2808–2816
Yamanashi Y, Baltimore D . 1997 Cell 88: 205–211
Zhang X, Ren R . 1998 Blood 92: 3829–3840
Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R . 2001a Mol. Cell. Biol. 21: 840–853
Zhang X, Wong R, Hao SX, Pear WS, Ren R . 2001b Blood 97: 277–287
Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS . 2002 Nat. Struct. Biol. 7: 7
Acknowledgements
We thank the members of the University of Pennsylvania John Morgan (IHGT) mouse and flow cytometry facilities. The flow cytometry studies were performed in the University of Pennsylvania Cancer Center Flow Cytometry and Cell Sorting Shared Resource (supported in part by the Lucille B Markey Trust and the NIH). Tissue processing was performed by the Gastroenterology Cell Morphology Core at the University of Pennsylvania (supported by NIH Center grant P30-DK50306). These studies were supported by NIH CA77570 and a Scholar Award from the Leukemia and Lymphoma Society to WS Pear. JA Wertheim acknowledges support from the Whitaker Foundation and the Medical Scientist Training Program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wertheim, J., Miller, J., Xu, L. et al. The biology of chronic myelogenous leukemia:mouse models and cell adhesion. Oncogene 21, 8612–8628 (2002). https://doi.org/10.1038/sj.onc.1206089
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206089
- Springer Nature Limited
Keywords
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.